## 

## 



## 

## 

## 

## 

|Contents|||||
|---|---|---|---|---|
|||||Pages|
|Members ofthe board|and professional|advisers|||
|Chair's statement|||||
|Trustees'<br>annual report||||3to 4|
|Strategic report|||||
|Responsibilities<br>ofthe Trustees|||||
|Independent<br>examiner's|report to the members||||
|Statement offinancial activities (incorporating<br>income and expenditure<br>account)|||the||
|Balance sheet|||||
|Statement ofCash Flow||||10|
|Notes to the financial<br>statements||||11to 17|





## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|Income and endowments|Note|Unrestricted<br>funds|Restricted<br>funds|Total funds<br>2021|Total funds<br>2020|
|---|---|---|---|---|---|
|Donations<br>and legacies<br>Other trading activities<br>Investment<br>income||507,013<br>43,148<br>8 170|269|507482<br>43,148<br>~8170|254,739<br>62,847<br>21 156|
|Total income and endowments||558 331|269|~558600|338742|
|Expenditure||||||
|Raising funds<br>Expenditure<br>on charitable<br>activities||6,277<br>659023|2~7398|6,277<br>686421|5,253<br>547966|
|Total expenditure||665 300|27398|692698|553219|
|Gains/(losses)<br>on||||||
|investments||49413||~49413|11 182|
|Net income (expenditure)<br>and net movement<br>in funds||||||
|for the year<br>Reconciliation offunds||(57,556)|(27,129)|($4,6$5)|(225,659)|
|Total funds brought<br>forward||~1230981|39407|~127038$|~1496047|
|Total funds carried forward||||||





## 




## 

## 

||||2021|2020|
|---|---|---|---|---|
|||Note|g||
|Cash flows from operating|activities||||
|Net cash income/(expenditure)|||(84,685)|(225,659)|
|Adjustments<br>for:|||||
|(increase) in debtors<br>Increase/(decrease)<br>in creditors<br>(Gains)/losses<br>on investment<br>Dividends,<br>interest and rents from investments||11<br>13<br>12<br>4|(188,463)<br>(339,413)<br>(49,413)<br>7,401|(180,208)<br>429,462<br>11,182<br>18,94|
|Net cash provided<br>by/ (used|in) operating activities||(669,375)|15,831|
|Cash flows from investing<br>activities|||||
|Dividends,<br>interest and rents from investments<br>Proceeds from sale ofinvestments<br>Purchase ofinvestments||4<br>12<br>12|7,401<br>120,068<br>254,710|18,946<br>498,827|
|Net cash flows Rom investing|activities||127,241|517,773|
|Net (decrease)/increase<br>in cash and cash equivalents|||(796,616)|533,604|
|Cash and cash equivalents<br>at|I April||1421,035|687,431|
|Cash and cash equivalents<br>at|31March||424419|1,221 035|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

||Unrestricted|Restricted|Total funds|
|---|---|---|---|
||funds|funds|2021|
|Donations||||
|Donations<br>Legacies|30,344|269|30,613|
|Legacies<br>Gifts|463,908||463,90$|
|In memoriam|12761||~12761|
||~50 3|||
|Year ended 31March 2020||||
|Donations||||
|Donations<br>Legacies|37,426|30,399|67,825|
|Legacies<br>Gifts|176,000||176,000|
|In memoriam|10914|-|10914|
||||~4|





## 

## 

## 

## 

## 

|||||Unrestricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
|||||funds|2021|2020|
||Fundraising<br>events<br>Income from sales ofmerchandise|||38,723<br>~4425|8<br>38,723<br>~4425|58,120<br>4727|
|4.|Income from investments||||||
|||||Unrestricted|Total funds|Total funds|
||Bank interest receivable<br>Interest from Government<br>Income from Open Ended|stocks<br> Investment|Companies|funds<br>f<br>769<br>413<br>6988|2021<br>769<br>413<br>6~988|2020<br>2,210<br>540<br>18406|
|5.|Expenditure<br>on raising funds||||||
|||||Unrestricted|Total funds|Total funds|
|||||funds|2021|2020|
||Cost ofgoods sold and other costs<br>Investment<br>management<br>fees|||3,297<br>2 980|3,297<br>~2980|1,402<br>~3851|
|6.|Expenditure<br>on charitable|activities|||||
|||||Unrestricted|Restricted|Total funds|
|||||funds|funds|2021|
||Medical supplies/equipment<br>Refurbishment<br>costs<br>Other charitable<br>donations<br>Office salaries|||27,245<br>480,260<br>117,164|27,245<br>153|54,490<br>480460<br>117/17|
||Administration<br>and other costs|||25,744<br>8610||25,744<br>~8610|
|||||~62|~9||
||Year ended 31March 2020||||||
||Medical supplies/equipment<br>Laboratory/research<br>Refurbishment<br>costs<br>Other charitable<br>donations<br>Office salaries|||1,741<br>435<br>489,367<br>17,210|900|2,641<br>435<br>489,367<br>17,210|
||Administration<br>and other costs|||26,163<br>12 150||26,163<br>12 150|
|||||~40 6|~9|54446|





## 

## 

## 

## 

|||||||2021|||2020|
|---|---|---|---|---|---|---|---|---|---|
||Realised gains(losses)<br>Unrealised<br>gains (losses)|||||3,462<br>~45 51|||118,844<br>~130026|
|8.|Net (expenditure)<br>income|||||||||
||This is stated after charging:|||||||||
|||||||2021|||2020|
||Independent<br>examiner's<br>fee|||||2,340|||2,340|
|9.|Stan'costs and emoluments|||||||||
||Total staff costs were as follows:|||||||||
|||||||2021|||2020|
||Wages and salaries<br>Pension contributions|||||24,500<br>~1244|||24,917<br>I246|
||Particulars ofemployees:|||||||||
||The<br>avemge<br>number<br>of employees<br>equivalents,<br>was as follows:||during|the|year,|calculated|on the|basis of|full-time|
|||||||2021|||2020|
||Number ofadministrative<br>staff|||||No|||No|
||No employee received remuneration|of|more than f60,000|||during the|year (2020-Nil).|||



## 




## 

## 

## 

## 

|Debtors|||
|---|---|---|
||2021|2020|
|Legacies receivable<br>Sundry debts receivable<br>Prepayments<br>Investment<br>income receivable|418,969<br>4,895<br>184<br>147|225,000<br>10,402<br>184<br>146|
|||~32|
|Investments|||
||2021|2020|
|At I April 2020<br>Investment<br>additions<br>Investment<br>disposals<br>Realised investment<br>gains (losses)<br>Unreslised<br>investment<br>gains (losses)|251,763<br>254,710<br>(120,068)<br>3,462<br>~45951|761,773<br>(498,827)<br>118,844<br>~130026|
|At 31 March 2021||~26|
|Listed investments<br>comprise:|||
||2021|2020|
|UK Government<br>Stocks<br>Open Ended Investment<br>Companies<br>Corporate bond funds|24,096<br>377,608<br>~34114|24,480<br>190,100<br>37 183|



## 

## 




## 

## 

## 

## 

|Restricted|income funds|||||
|---|---|---|---|---|---|
|||Balance||||
|Equipment <br>Equipment|- hearts<br> - other|at I April<br>2020<br>31,541<br>7866|Income <br>100<br>169|Expenditure<br>t<br>(27,245)<br>~153|Balance<br>at31March<br>2021<br>4,396<br>7882|
|||Balance||||
|||at I April<br>2019|Income|Expenditure|Balance<br>at 31March<br>2020|
|Equipment<br>Equipment<br>|-hearts<br>—other<br>|3,666<br>6242<br>~90<br>|28,775<br>1 623<br>~9|(900)<br>~90|c<br>31,541<br>7865<br>~40|



## 

|||Balance at|||Investment||
|---|---|---|---|---|---|---|
|General|funds|IApr 2020|Income|Expenditure|gains/(lease<br>s)|Balance at<br>31Mar 2021|
|||Balance at|||||
|General|funds|1Apr 2019<br>~41|Income<br>~3|Expenditure|losses on<br>investments|Balance at<br>31Mar 2020<br>~98|





## 

## 

## 

## 

## 

## 

||As at31March 2021||Net current||
|---|---|---|---|---|
||Restricted funds|Investments|assets|Total|
||Unresuicted<br>funds<br>Total funds|435818|12,278<br>737607|12,278<br>1173425|
|||||~1185703|
||As at31March 2020||Net current||
||Restricted funds|Investments|assets|Total<br>s|
|Unrestricted<br>funds<br>Total funds<br>17.Analysis ofnet debt||251 763|39,407<br>~979<br>18<br>~0$|39,407<br>1230981<br>~38|
||Cash at bank and in hand|At I April 2020|Cash flow|At 31March<br>2021|
||Net debt|~1221035|~796616|424419|
||||~9~~66|424419|
||Cash at bank and in hand<br>Net debt|At 1April 2019<br>687431|At 31March<br>Cash flow<br>2020<br>533604<br>1 221 035<br>~34||
|18.|Related parties||||